Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Mel B. Feany, M.D., Ph.D.

Co-Author

This page shows the publications co-authored by Mel Feany and Clemens Scherzer.
Connection Strength

0.941
  1. Yeast genetics targets lipids in Parkinson's disease. Trends Genet. 2004 Jul; 20(7):273-7.
    View in: PubMed
    Score: 0.304
  2. Gene expression changes presage neurodegeneration in a Drosophila model of Parkinson's disease. Hum Mol Genet. 2003 Oct 01; 12(19):2457-66.
    View in: PubMed
    Score: 0.285
  3. Biotin rescues mitochondrial dysfunction and neurotoxicity in a tauopathy model. Proc Natl Acad Sci U S A. 2020 12 29; 117(52):33608-33618.
    View in: PubMed
    Score: 0.237
  4. Lysosomal dysfunction promotes cleavage and neurotoxicity of tau in vivo. PLoS Genet. 2010 Jul 15; 6(7):e1001026.
    View in: PubMed
    Score: 0.115
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.